NCT07114159

Long-term Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis

An Open-label Clinical Trial to Evaluate the Long-term Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 15 (estimated)
• Sponsor: Xijing Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

Although the incidence of inflammatory bowel disease is stable in North American and European countries, the incidence of inflammatory bowel disease is increasing in newly industrialized countries, especially in China. The treatment drugs for ulcerative colitis include 5-aminosalicylic acid (5-ASA), glucocorticoids, immunosuppressants, and biological agents. The aim of this clinical trial is to evaluate the long-term safety and efficacy of sacral nerve stimulation in patients with ulcerative colitis

Conditions

• Ulcerative Colitis

Interventions

Type	Name	Description
DEVICE	Sacral nerve stimulation	Device: G132 system, Beijing PINS Medical Co., China Neuromodulation was performed according to the usual protocol

Timeline

• Start date: 2025-08-02
• Primary completion: 2032-12-01
• Completion: 2032-12-01
• First posted: 2025-08-11
• Last updated: 2025-08-11

Locations

1 site across 1 country: China